L

Leyi Yao

Guangdong Medical College

ORCID: 0009-0009-1987-7770

26 papers and 496 citations.

PubIndex Score94Top 6% · mid-careerHow it's scored

26Publications

496Total Citations

First publication: 2022First senior author: 2025

Top publicationsby citations

Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells

Leyi Yao, Jinbao Liu|Cancer Biology and Medicine|2022

Cited by 8

Indexing the rest of 26 publications…